Johnson Financial Group, Inc. Prothena Corp Public LTD CO Transaction History
Johnson Financial Group, Inc.
- $2.64 Billion
- Q3 2025
A detailed history of Johnson Financial Group, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 151 shares of PRTA stock, worth $1,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151Holding current value
$1,499% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
216Shares Held
34.3MCall Options Held
769KPut Options Held
1.1M-
Black Rock Inc. New York, NY3.86MShares$38.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$22.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$20.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY1.54MShares$15.3 Million0.25% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.47MShares$14.6 Million1.35% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $466M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...